High-Density Lipoprotein Cholesterol: A Component of the Metabolic Syndrome with a New Role in Lung Function
Table 2
Regression coefficients of each metabolic component individually entered into adjusted models for predicting FVC (% predicted), FEV1 (% predicted), and FEV1/FVC ratio.
FVC (% predicted)
FEV1 (% predicted)
FEV1/FVC ratio
Men
Women
Men
Women
Men
Women
Variables
β (SE)
β (SE)
β (SE)
β (SE)
β (SE)
β (SE)
WC (cm)
−0.067 (0.038)
0.041 (0.039)
−0.057 (0.039)
0.037 (0.038)
0.041 (0.030)
0.007 (0.030)
SBP (mmHg)
−0.070 (0.028)
−0.058 (0.028)
−0.080 (0.029)
−0.017 (0.028)
−0.005 (0.023)
0.030 (0.022)
DBP (mmHg)
0.100 (0.040)
0.068 (0.042)
0.068 (0.041)
0.037 (0.042)
−0.028 (0.032)
−0.014 (0.032)
FPG (mmol/L)
0.056 (0.450)
0.034 (0.429)
0.028 (0.459)
0.007 (0.424)
−0.032 (0.359)
−0.014 (0.329)
TG (mmol/L)
−0.003 (0.499)
−0.028 (0.464)
0.032 (0.509)
−0.007 (0.459)
0.038 (0.398)
0.021 (0.357)
HDL-C (mmol/L)
−0.068 (1.233)
−0.136 (1.120)
−0.029 (1.257)
−0.100 (1.109)
0.054 (0.984)
0.013 (0.861)
Data were calculated using multiple linear regression. Adjustments were made for age and family income group. WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides; FVC, forced vital capacity; FEV1, forced expiratory volume in 1 s; SE, standard error. ,, and .
